IMPOWER 22

soon-to-launch

IMPOWER 22

Jan 8, 2023

A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. ICAP...

soon-to-launch

IMPOWER 22

Enter keyword:

Select a category:

Select a tag:

Select a location:

Now on Bluesky

Now on Bluesky